Pages that link to "Q42351696"
Jump to navigation
Jump to search
The following pages link to c-Myc and cancer metabolism (Q42351696):
Displaying 50 items.
- MYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical management (Q26785379) (← links)
- SGF29 and Sry pathway in hepatocarcinogenesis (Q26795760) (← links)
- Is cancer a metabolic disease? (Q26852241) (← links)
- Adaptations of energy metabolism during cerebellar neurogenesis are co-opted in medulloblastoma (Q27015699) (← links)
- O-GlcNAcylation and Metabolic Reprograming in Cancer (Q27027028) (← links)
- Tumor Metabolism, the Ketogenic Diet and β-Hydroxybutyrate: Novel Approaches to Adjuvant Brain Tumor Therapy (Q28069398) (← links)
- Changing perspective on oncometabolites: from metabolic signature of cancer to tumorigenic and immunosuppressive agents (Q28073524) (← links)
- Evaluation of Cysteinyl Leukotriene Signaling as a Therapeutic Target for Colorectal Cancer (Q28074285) (← links)
- Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents (Q28075606) (← links)
- Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis (Q28075646) (← links)
- New aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cells (Q28534587) (← links)
- New MYC IHC Classifier Integrating Quantitative Architecture Parameters to Predict MYC Gene Translocation in Diffuse Large B-Cell Lymphoma (Q30489244) (← links)
- Combinational delivery of c-myc siRNA and nucleoside analogs in a single, synthetic nanocarrier for targeted cancer therapy. (Q30572043) (← links)
- Three steps to the immortality of cancer cells: senescence, polyploidy and self-renewal (Q33590178) (← links)
- Targeting MYC Dependence by Metabolic Inhibitors in Cancer (Q33608493) (← links)
- c-MYC-Making Liver Sick: Role of c-MYC in Hepatic Cell Function, Homeostasis and Disease. (Q33608524) (← links)
- Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward (Q33624574) (← links)
- RIZ1 negatively regulates ubiquitin-conjugating enzyme E2C/UbcH10 via targeting c-Myc in meningioma (Q33733305) (← links)
- Halogenated diarylacetylenes repress c-myc expression in cancer cells (Q33896483) (← links)
- Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? (Q33917658) (← links)
- Epidermal growth factor receptor (EGFR) signaling regulates global metabolic pathways in EGFR-mutated lung adenocarcinoma (Q33947130) (← links)
- Fibrillarin from Archaea to human (Q34043464) (← links)
- Evaluation of the antitumor effects of c-Myc-Max heterodimerization inhibitor 100258-F4 in ovarian cancer cells (Q34161727) (← links)
- In vivo antitumor and antimetastatic effects of flavokawain B in 4T1 breast cancer cell-challenged mice. (Q35174206) (← links)
- Hepatitis B Virus Pre-S2 Mutant Induces Aerobic Glycolysis through Mammalian Target of Rapamycin Signal Cascade. (Q35536490) (← links)
- Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer. (Q35552855) (← links)
- The crossroads between cancer stem cells and aging. (Q35566484) (← links)
- Clinicopathologic Features and Molecular Characteristics of Glucose Metabolism Contributing to ¹⁸F-fluorodeoxyglucose Uptake in Gastrointestinal Stromal Tumors (Q35824518) (← links)
- Discovery of a Family of Genomic Sequences Which Interact Specifically with the c-MYC Promoter to Regulate c-MYC Expression. (Q36110185) (← links)
- Glycolytic inhibitor 2-deoxyglucose simultaneously targets cancer and endothelial cells to suppress neuroblastoma growth in mice (Q36175385) (← links)
- Simulating Heterogeneous Tumor Cell Populations (Q36234846) (← links)
- MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism. (Q36326344) (← links)
- Targeting cancer metabolism (Q36330869) (← links)
- Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells. (Q36385397) (← links)
- HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer (Q36545260) (← links)
- Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth (Q36562311) (← links)
- In silico pathway analysis in cervical carcinoma reveals potential new targets for treatment (Q36771946) (← links)
- Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma (Q36772125) (← links)
- Manganese superoxide dismutase deficiency triggers mitochondrial uncoupling and the Warburg effect (Q36879121) (← links)
- Glucose induced activation of canonical Wnt signaling pathway in hepatocellular carcinoma is regulated by DKK4. (Q36980627) (← links)
- Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia (Q37137148) (← links)
- Mitophagy-driven mitochondrial rejuvenation regulates stem cell fate (Q37194210) (← links)
- LTβR signalling preferentially accelerates oncogenic AKT-initiated liver tumours (Q37282535) (← links)
- Methylglyoxal suppresses human colon cancer cell lines and tumor growth in a mouse model by impairing glycolytic metabolism of cancer cells associated with down-regulation of c-Myc expression (Q37283010) (← links)
- Proteomic profiling of lung adenocarcinoma indicates heightened DNA repair, antioxidant mechanisms and identifies LASP1 as a potential negative predictor of survival (Q37374550) (← links)
- cMYC expression in infiltrating gliomas: associations with IDH1 mutations, clinicopathologic features and outcome (Q37435393) (← links)
- Altered glutamine metabolism in platinum resistant ovarian cancer (Q37520321) (← links)
- Anti-miR-203 suppresses ER-positive breast cancer growth and stemness by targeting SOCS3 (Q37629076) (← links)
- c-Myc quadruplex-forming sequence Pu-27 induces extensive damage in both telomeric and nontelomeric regions of DNA. (Q37653320) (← links)
- MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4. (Q37688166) (← links)